EG23836A - A novel salt - Google Patents

A novel salt

Info

Publication number
EG23836A
EG23836A EG52698A EG52698A EG23836A EG 23836 A EG23836 A EG 23836A EG 52698 A EG52698 A EG 52698A EG 52698 A EG52698 A EG 52698A EG 23836 A EG23836 A EG 23836A
Authority
EG
Egypt
Prior art keywords
novel salt
salt
novel
Prior art date
Application number
EG52698A
Other languages
English (en)
Inventor
Alastair C Brodie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10812407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG23836(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of EG23836A publication Critical patent/EG23836A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
EG52698A 1997-05-17 1998-05-14 A novel salt EG23836A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt

Publications (1)

Publication Number Publication Date
EG23836A true EG23836A (en) 2007-10-02

Family

ID=10812407

Family Applications (1)

Application Number Title Priority Date Filing Date
EG52698A EG23836A (en) 1997-05-17 1998-05-14 A novel salt

Country Status (51)

Country Link
US (1) US6294540B1 (is)
EP (1) EP0983271B1 (is)
JP (2) JP3150711B2 (is)
KR (1) KR100521292B1 (is)
CN (2) CN100408580C (is)
AP (1) AP2009A (is)
AR (2) AR015668A1 (is)
AT (1) ATE259811T1 (is)
AU (1) AU739953B2 (is)
BG (1) BG64390B1 (is)
BR (1) BRPI9809126B8 (is)
CA (1) CA2289753C (is)
CO (1) CO4940435A1 (is)
DE (1) DE69821758T2 (is)
DK (1) DK0983271T3 (is)
DZ (1) DZ2493A1 (is)
EA (1) EA001809B1 (is)
EE (1) EE03924B1 (is)
EG (1) EG23836A (is)
ES (1) ES2214712T3 (is)
GB (3) GB9709945D0 (is)
GE (1) GEP20022680B (is)
HK (1) HK1024236A1 (is)
HN (1) HN1998000071A (is)
HR (1) HRP980265B1 (is)
HU (1) HU226563B1 (is)
ID (1) ID24910A (is)
IL (2) IL132793A0 (is)
IS (1) IS2207B (is)
JO (1) JO2032B1 (is)
MA (1) MA26498A1 (is)
MY (1) MY120151A (is)
NO (1) NO324731B1 (is)
NZ (2) NZ510622A (is)
OA (1) OA11304A (is)
PA (1) PA8451301A1 (is)
PE (1) PE78799A1 (is)
PL (1) PL189527B1 (is)
PT (1) PT983271E (is)
RS (1) RS49655B (is)
SA (1) SA98190179B1 (is)
SI (1) SI0983271T1 (is)
SK (1) SK285159B6 (is)
SV (1) SV1998000057A (is)
TN (1) TNSN98065A1 (is)
TR (1) TR199902810T2 (is)
TW (1) TW480259B (is)
UA (1) UA56231C2 (is)
UY (1) UY25004A1 (is)
WO (1) WO1998052949A1 (is)
ZA (2) ZA984083B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (en) 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2079741B1 (en) * 2006-09-28 2014-11-26 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
PT2531027E (pt) 2010-01-27 2015-09-16 Viiv Healthcare Co Combinação terapêutica compreendendo dolutegravir, abacavir e lamivudina
WO2012137227A2 (en) 2011-04-08 2012-10-11 Laurus Labs Private Limited Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof
EP2962693B1 (en) 2013-02-27 2019-01-09 Kyoto University Pharmaceutical composition comprising abacavir for the treatment of cancer
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
CZ429398A3 (cs) * 1996-06-25 1999-05-12 Glaxo Group Limited Kombinace účinných látek a farmaceutický prostředek

Also Published As

Publication number Publication date
TNSN98065A1 (fr) 2005-03-15
AP9901688A0 (en) 1999-12-31
GB2348202B (en) 2001-08-08
EP0983271B1 (en) 2004-02-18
BRPI9809126B1 (pt) 2018-02-06
CA2289753A1 (en) 1998-11-26
UA56231C2 (uk) 2003-05-15
ES2214712T3 (es) 2004-09-16
SA98190179B1 (ar) 2006-08-15
OA11304A (en) 2003-10-22
MA26498A1 (fr) 2004-12-20
CN1515572A (zh) 2004-07-28
PE78799A1 (es) 1999-08-31
GB2340491B (en) 2000-10-18
DE69821758D1 (de) 2004-03-25
EP0983271A1 (en) 2000-03-08
TW480259B (en) 2002-03-21
UY25004A1 (es) 2000-10-31
BR9809126A (pt) 2000-08-01
PT983271E (pt) 2004-07-30
HUP0002754A3 (en) 2003-01-28
NO324731B1 (no) 2007-12-03
GEP20022680B (en) 2002-04-25
HRP980265A2 (en) 1999-02-28
AR015668A1 (es) 2001-05-16
ID24910A (id) 2000-08-31
EE03924B1 (et) 2002-12-16
TR199902810T2 (xx) 2000-02-21
DZ2493A1 (fr) 2004-06-20
JO2032B1 (en) 1999-05-15
IL132793A0 (en) 2001-03-19
AU7765598A (en) 1998-12-11
DK0983271T3 (da) 2004-05-10
AU739953B2 (en) 2001-10-25
NO995622L (no) 2000-01-14
SK285159B6 (sk) 2006-07-07
AR059120A2 (es) 2008-03-12
YU59599A (is) 2002-08-12
AP2009A (en) 2009-06-26
EE9900537A (et) 2000-06-15
RS49655B (sr) 2007-09-21
NO995622D0 (no) 1999-11-16
CA2289753C (en) 2007-01-23
KR20010012623A (ko) 2001-02-26
HUP0002754A2 (hu) 2001-06-28
NZ500865A (en) 2001-04-27
EA001809B1 (ru) 2001-08-27
HRP980265B1 (en) 2004-10-31
SK156199A3 (en) 2000-07-11
SI0983271T1 (en) 2004-06-30
ATE259811T1 (de) 2004-03-15
CN1150194C (zh) 2004-05-19
ZA984083B (en) 1999-11-15
MY120151A (en) 2005-09-30
PL189527B1 (pl) 2005-08-31
JP2000327679A (ja) 2000-11-28
JP3150711B2 (ja) 2001-03-26
BRPI9809126B8 (pt) 2021-07-06
NZ510622A (en) 2002-04-26
DE69821758T2 (de) 2005-01-13
GB9709945D0 (en) 1997-07-09
GB0010222D0 (en) 2000-06-14
IS2207B (is) 2007-02-15
CO4940435A1 (es) 2000-07-24
HK1024236A1 (en) 2000-10-05
CN1263529A (zh) 2000-08-16
HU226563B1 (en) 2009-04-28
BG103959A (en) 2000-12-29
PA8451301A1 (es) 2000-05-24
GB2348202A (en) 2000-09-27
JP2000514096A (ja) 2000-10-24
GB9926839D0 (en) 2000-01-12
WO1998052949A1 (en) 1998-11-26
ZA984085B (en) 2000-01-26
US6294540B1 (en) 2001-09-25
EA199900944A1 (ru) 2000-06-26
SV1998000057A (es) 1999-03-02
CN100408580C (zh) 2008-08-06
GB2340491A (en) 2000-02-23
BG64390B1 (bg) 2004-12-30
HN1998000071A (es) 1999-03-19
IL132793A (en) 2006-10-31
KR100521292B1 (ko) 2005-10-17
PL336888A1 (en) 2000-07-17
IS5246A (is) 1999-11-11

Similar Documents

Publication Publication Date Title
EG23836A (en) A novel salt
IL133234A0 (en) A new salt
EG21217A (en) A metallogene compounds
AU135652S (en) A wristwatch
GB2331915B (en) A mit
GB2330773B (en) A skin-moisturising preparation
GB2321259B (en) A structural member
GB2324029B (en) A hanger
SI0984952T1 (en) A new salt
GB9717959D0 (en) A holdall
GB9719559D0 (en) A better way
IL120253A0 (en) A screw - wrench
AU132788S (en) A pareo
AU135496S (en) A crumpet
GB9712190D0 (en) A book-end
AU132787S (en) A pareo
AU133234S (en) A teapot-container
GB9715367D0 (en) A dredgehead
AU129750S (en) A case
AU129626S (en) A time piece
ZA988491B (en) A time piece
AU129522S (en) A time piece
AU131134S (en) A section
AU131919S (en) A section
AU135968S (en) A section